Long-Legged Cats Inform Genetics Studies - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Long-Legged Cats Inform Genetics Studies

  • October 26, 2026

  • 2 min

Share

Clinical Scorecard: Long-Legged Cats Inform Genetics Studies

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Long-Legged Cats Inform Genetics Studies
Key MechanismsBoth cats carried two copies of a rare FBN1 variant. Long-read RNA sequencing of the affected cat found that approximately 73% of FBN1 transcripts lacked exon 22; the remaining transcripts retained it.
Target PopulationPatients or participants described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • Both cats had displaced eye lenses, unusually long limbs, and severe aortic enlargement.
  • Whole-genome sequencing identified the same rare FBN1 variant in both cats; it was absent from genomic data representing more than 1,000 other cats.
  • Long-read RNA sequencing of the affected cat showed that approximately 73% of FBN1 transcripts lacked exon 22.
  • The remaining transcripts retained exon 22, which the authors say may allow some normal fibrillin-1 production.
  • The study involved two related animals and did not directly analyze fibrillin-1 protein production.

Guideline-Based Recommendations

Diagnosis

  • The study describes combining clinical findings, tissue pathology, genomic sequencing, and RNA analysis to investigate the consequences of a rare genetic variant.

Management

    Monitoring & Follow-up

      Risks

      • The findings are limited to two related cats.
      • Fibrillin-1 protein production was not directly analyzed.
      • The authors report that DNA sequencing alone may be insufficient to establish whether a genetic variant causes disease.

      Patient & Prescribing Data

      Two male domestic-cat littermates with features of Marfan syndrome; no treatment or prescribing data are reported.

      The article reports genetic and RNA analyses, not treatment.

      Clinical Best Practices

      • The authors describe combining clinical findings, tissue pathology, genomic sequencing, and RNA analysis to investigate the consequences of a rare genetic variant.
      • Interpret the findings in light of the study's limitations: two related animals and no direct analysis of fibrillin-1 protein production.

      Related Resources & Content

      Original Source(s)

      Related Content